Lividomicin
{{Drugbox-lat| IUPAC_name = (1R,2R,3S,4R,6S)-4,6-Diamino-3-hidroksi-2-{[α-D-manopiranozil-(1->4)-2,6-diamino-2,6-dideoksi-β-L-idopiranozil-(1->3)-β-D-ribofuranozil]oksi}cikloheksil 2-amino-2,3-dideoksi-α-D-ribo-heksopiranozid| image = Lividomycin.svg| width =| image2 =| width2 =| CAS_number_Ref = 
| CAS_number = 36441-41-5| ATC_prefix = none| ATC_suffix = | PubChem = 72394| IUPHAR_ligand =| ChEMBL_Ref =| ChEMBL =| DrugBank_Ref =| DrugBank = DB04728| ChemSpiderID = 65327| C=29 | H=55 | N=5 |O=19| molecular_weight = 777,769 g/mol| smiles = O([C@H]4[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@H]2O[C@@H](CN)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)[C@H](O)[C@H]2N)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]4N)[C@H]5O[C@@H]([C@@H](O)C[C@H]5N)CO| StdInChI_Ref = | StdInChI = 1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1| StdInChIKey_Ref = | StdInChIKey = DBLVDAUGBTYDFR-SWMBIRFSSA-N| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = }}
Lividomicin je aminoglikozidni antibiotik.
